Literature DB >> 29486949

Unprecedented sugar bridged bisindoles selective inhibiting glioma stem cells.

Xin Wei1, Zhi Dai2, Jing Yang3, Afsar Khan4, Hao-Fei Yu1, Yun-Li Zhao3, Yi-Fen Wang3, Ya-Ping Liu3, Zi-Feng Yang5, Wan-Yi Huang5, Xin-Hua Wang6, Xu-Dong Zhao7, Xiao-Dong Luo8.   

Abstract

Unlike reported bisindoles linked by single bond directly, alstoniasidines A (1) and B (2), from Alstonia scholaris featuring unprecedented skeleton with two indole moieties bridged by a sugar, represented a novel bisindole type having strictosamide-glucopyranose-picraline scaffold. Both compounds exhibited selective cytotoxicity against human glioma stem cells (GSCs) and induced caspase-3 dependent extrinsic apoptosis by increasing the expression of interleukin 1 (IL-1), tumor necrosis factor (TNF-α), and the cleaved caspase-3, while damaged the unlimited proliferation and self-renewal capacity of GSCs. This finding might provide new type of leads for the selective killing of human glioma stem cells.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Alstonia scholaris; Alstoniasidines A and B; Glioma stem cells; Sugar bridged bisindole

Mesh:

Substances:

Year:  2018        PMID: 29486949     DOI: 10.1016/j.bmc.2018.02.024

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  2 in total

1.  Indole alkaloids of Alstonia scholaris (L.) R. Br. alleviated nonalcoholic fatty liver disease in mice fed with high-fat diet.

Authors:  Shui-Fen Sun; Hui-Jie Zhong; Yun-Li Zhao; Xiu-Ying Ma; Jin-Bo Luo; Ling Zhu; Yu-Ting Zhang; Wen-Xue Wang; Xiao-Dong Luo; Jia-Wei Geng
Journal:  Nat Prod Bioprospect       Date:  2022-04-02

2.  New Monoterpenoid Indoles with Osteoclast Activities from Gelsemium elegans.

Authors:  Xin Wei; Rui Guo; Xiao Wang; Jia-Jun Liang; Hao-Fei Yu; Cai-Feng Ding; Ting-Ting Feng; Li-Yan Zhang; Xia Liu; Xin-Yue Hu; Ying Zhou
Journal:  Molecules       Date:  2021-12-09       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.